Private Life Biomed
3
45M
2
0.14
0.33
- Stages of investment
- Areas of investment
Summary
Private Life Biomed is the famous Corporate Investor, which was founded in 2000. The leading representative office of defined Corporate Investor is situated in the Hamburg. The company was established in Europe in Germany.
Among the most popular portfolio startups of the fund, we may highlight Perlegen Sciences, EyeSense AG. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2006. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Private Life Biomed, startups are often financed by Unilever Ventures, SB Life Science, Maverick Ventures. The meaningful sponsors for the fund in investment in the same round are Zesiger Capital, Unilever Ventures, Sano Ventures. In the next rounds fund is usually obtained by Zesiger Capital, Unilever Ventures, Sano Ventures.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Rounds per year
- 0.14
- Follow on index
- 0.33
- Investments by industry
- Health Care (3)
- Biotechnology (2)
- Pharmaceutical (2)
- Genetics (2)
- Medical (1) Show 1 more
- Investments by region
-
- United States (2)
- Germany (1)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| EyeSense AG | 10 Feb 2006 | Health Care, Health Diagnostics, Medical | Early Stage Venture | 11M | Germany, Bavaria, Germany |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.